Federated Hermes, Inc. Corcept Therapeutics Inc Transaction History

Federated Hermes, Inc.

  • $41.2 Billion
  • Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 38,759 shares of CORT stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,759
Previous 49,906 22.34%
Holding current value
$1.7 Million
Previous $1.26 Million 0.16%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$22.21 - $34.48 $247,574 - $384,348
-11,147 Reduced 22.34%
38,759 $1.26 Million
Q1 2024

May 14, 2024
SELL
$21.1 - $27.46 $34.6 Million - $45 Million
-1,639,823 Reduced 97.05%
49,906 $1.26 Million
Q4 2023

Jan 31, 2024
SELL
$24.82 - $32.88 $40,828 - $54,087
-1,645 Reduced 0.1%
1,689,729 $54.9 Million
Q3 2023

Nov 13, 2023
SELL
$21.97 - $33.8 $23.5 Million - $36.1 Million
-1,068,922 Reduced 38.72%
1,691,374 $46.1 Million
Q1 2023

May 08, 2023
SELL
$19.2 - $24.47 $9.82 Million - $12.5 Million
-511,579 Reduced 15.64%
2,760,296 $59.8 Million
Q4 2022

Feb 13, 2023
SELL
$19.95 - $29.96 $45.5 Million - $68.3 Million
-2,278,925 Reduced 41.06%
3,271,875 $66.5 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $340,860 - $401,856
13,800 Added 0.25%
5,550,800 $142 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $13.8 Million - $20.2 Million
796,580 Added 16.8%
5,537,000 $132 Million
Q1 2022

May 13, 2022
BUY
$16.53 - $25.21 $1.89 Million - $2.89 Million
114,571 Added 2.48%
4,740,420 $107 Million
Q4 2021

Feb 14, 2022
BUY
$17.1 - $23.34 $13.1 Million - $17.9 Million
764,849 Added 19.81%
4,625,849 $91.6 Million
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $23.9 Million - $27.4 Million
-1,215,507 Reduced 23.94%
3,861,000 $76 Million
Q4 2020

Feb 12, 2021
SELL
$16.78 - $27.3 $2.03 Million - $3.3 Million
-120,706 Reduced 2.32%
5,076,507 $133 Million
Q3 2020

Nov 12, 2020
BUY
$12.46 - $19.98 $1.28 Million - $2.06 Million
103,032 Added 2.02%
5,197,213 $90.5 Million
Q2 2020

Aug 13, 2020
SELL
$11.0 - $18.26 $1.35 Million - $2.24 Million
-122,651 Reduced 2.35%
5,094,181 $85.7 Million
Q1 2020

May 13, 2020
SELL
$10.11 - $14.04 $37 Million - $51.4 Million
-3,657,568 Reduced 41.21%
5,216,832 $62 Million
Q4 2019

Feb 14, 2020
SELL
$12.06 - $16.96 $4.43 Million - $6.23 Million
-367,300 Reduced 3.97%
8,874,400 $107 Million
Q3 2019

Nov 14, 2019
SELL
$10.41 - $14.66 $10.7 Million - $15.1 Million
-1,028,392 Reduced 10.01%
9,241,700 $131 Million
Q2 2019

Aug 14, 2019
SELL
$9.78 - $12.76 $8.86 Million - $11.6 Million
-906,189 Reduced 8.11%
10,270,092 $115 Million
Q1 2019

May 10, 2019
SELL
$10.03 - $15.71 $4.3 Million - $6.73 Million
-428,508 Reduced 3.69%
11,176,281 $131 Million
Q4 2018

Feb 13, 2019
SELL
$11.29 - $17.19 $5.48 Million - $8.34 Million
-485,031 Reduced 4.01%
11,604,789 $155 Million
Q3 2018

Nov 13, 2018
BUY
$12.27 - $15.65 $2.08 Million - $2.66 Million
169,712 Added 1.42%
12,089,820 $169 Million
Q2 2018

Aug 10, 2018
SELL
$15.3 - $19.69 $11.7 Million - $15.1 Million
-766,619 Reduced 6.04%
11,920,108 $187 Million
Q1 2018

May 09, 2018
BUY
$14.59 - $25.5 $915,011 - $1.6 Million
62,715 Added 0.5%
12,686,727 $209 Million
Q4 2017

Feb 14, 2018
BUY
$15.77 - $20.72 $11.2 Million - $14.7 Million
708,219 Added 5.94%
12,624,012 $0
Q3 2017

Nov 13, 2017
BUY
$12.3 - $19.3 $147 Million - $230 Million
11,915,793
11,915,793 $230 Million

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email